Multiple Sclerosis Global Support Network News

"Your trusted source for the latest in MS news and information."

  • MS Info Hub
  • MS News

ECTRIMS 2017: Mark Freedman discusses recent developments and unmet needs in...

Mark Freedman discusses recent developments and unmet needs in MS. Mark Freedman has received honoraria or consultation fees from Bayer Healthcare, Biogen-Idec, Chugai, EMD Canada,...

CCVSI Ineffective Against MS Says The Procedures Originator Dr. Zamboni

A new study published by JAMA Neurology delivers a verdict on a long-debated theory that MS can be treated by opening blocked veins: it's...

Blood-Clotting Protein Prevents Repair in the Brain

Picture a bare wire, without its regular plastic coating. It’s exposed to the elements and risks being degraded. And, without insulation, it may not...

How rogue immune cells cross the blood-brain barrier to cause multiple...

Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a...

MSAA Launches Two Wonderful New Free Publications For Patients

CHERRY HILL, N.J., Nov. 16, 2017 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) has produced two new, free publications, which provide extensive information to the...

Age and gut bacteria contribute to multiple sclerosis disease progression

Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS)...

Multiple Sclerosis and the Self-Perception of Health

Multiple sclerosis (MS) is a disease of many and often diverse symptoms. Widely considered an autoimmune disorder, meaning that the immune system of an...

NICE (UK) Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis

- First multiple sclerosis (MS) therapy to achieve positive NICE recommendation in the shortest possible timeframe - Mavenclad has shown sustained clinical efficacy up to...

ECTRIMS 2017: T-cell vs. B-cell Debate More Meeting of Minds Than...

One particular session on Day 2 of the four-day 7th Joint ECTRIMS-ACTRIMS Meeting — which drew 10,000 researchers, doctors, industry representatives, and patient advocates to hear...

ECTRIMS 2017: Bruce Cree, MD, PhD: Brain Volume Loss and Disability...

Bruce Cree, MD, PhD, an associate professor of clinical neurology at UCSF Medical School, spoke with MD Magazine at MS Paris 2017 about the...

Subscribe To Our Newsletter